Clinical Trial Update: Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sofosbuvir plus ribavirin in treatment-naive adults with genotype 1 or 3 chronic hepatitis C completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2015-04-17